Dysregulation of the fibroblast growth factor system in major depression
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
In this report we describe findings that imply dysregulation of several fibroblast growth factor (FGF) system transcripts in frontal cortical regions of brains from human subjects with major depressive disorder (MDD). This altered gene expression was discovered by microarray analysis of frontal cortical tissue from MDD, bipolar, and nonpsychiatric control subjects and was verified by quantitative real-time PCR analysis and, importantly, in a separate cohort of MDD subjects. Furthermore, we show, through a separate analysis of specific serotonin reuptake inhibitor (SSRI)-treated and non-SSRI-treated MDD subjects that the observed changes in expression of FGF transcripts are not secondary to drug treatment. Rather, changes in specific FGF transcripts are attenuated by SSRIs and may thus be partially responsible for the mechanism of action of these drugs. We also make available the gene-expression profile of all of the other growth factors and growth factor receptors detected in these postmortem samples.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Post-mortem brain analysis in humans revealed a lower expression of FGF1 and FGF2 in the dorsolateral PFC and the ACC of patients with MDD (Evans et al. 2004).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Evans et al. 2004
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma
Gilbertson, M. W., Shenton, M. E., Ciszewski, A., Kasai, K., Lasko, N. B., Orr, S. P., & Pitman, R. K. (2002) · Nature Neuroscience · doi:10.1038/nn958 · Cited by 1,635
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151
Lee, J., Duan, W., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01085.x · Cited by 975
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001308 · Cited by 532
Tomita, H., Vawter, M. P., Walsh, D. M., Evans, S. J., Choudary, P. V., Li, J., Overman, K. M., Atz, M. E., Myers, R. M., Jones, E. G., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.013 · Cited by 331
Self-citationThe neuropathology of primary mood disorder
Harrison, P. J. (2002) · Brain · doi:10.1093/brain/awf149 · Cited by 322
López-Figueroa, A. L., Norton, C. S., López-Figueroa, M. O., Armellini-Dodel, D., Burke, S., Akil, H., López, J. F., & Watson, S. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.017 · Cited by 296
Self-citation
Research works printed but not linked: 4
- Watson S. J. Patel P. Burke S. Herman J. Shaffer M. & Kwak S. (1988) in Short Course 1 Syllabus ed. Sunderman A. (Soc. Neurosci. Washington DC) pp. 4-29.
- Neal, C. R., Jr., Akil, H. & Watson, S. J., Jr. (2001) J. Chem. Neuroanat. 22, 219-249.11719021
- Parikh, V., Evans, D. R., Khan, M. M. & Mahadik, S. P. (2003) Schizophr. Res. 60, 117-123.12591576
- Dono, R. (2003) Am. J. Physiol. 284, R867-R881.
Cited by
Items 301–400 of 466
Bryant, E. M., Richardson, R., & Graham, B. M. (2022) · Chronic Stress · doi:10.1177/24705470221114787 · Cited by 8
“Initial research showed decreased levels of FGF2 mRNA in the dorsolateral prefrontal cortex in post-mortem brain tissue from individuals with Major Depressive Disorder (MDD) relative to healthy controls.(12) Lower levels of serum FGF2 were found in adults with MDD(13) and children with anxiety and/or depressive sympto…”
BackgroundZhou, R., Zarate, C. A., & Manji, H. K. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006176 · Cited by 8
“…studies have been increasingly applied in researches on psychiatry disorders, including schizophrenia (Wong et al., 2004), major depression (Evans et al., 2004) and BD (Ogden et al., 2004), most of the studies have provided hitherto unnoticed genes or/ and mechanisms of mental disorders…”
BackgroundEpigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders
Boulle, F. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131129fb · Cited by 8
Neurotrophic Factors and Dendritic Spines
Halbach, O. V. B. U. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-36159-3_5 · Cited by 7
Shimada, T., Kohyama, K., Yoshida, T., & Yamagata, K. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.0129-23.2024 · Cited by 7
He, Y., Li, Y., Wei, Z., Zhang, X., Gao, J., Wang, X., Li, X., Wu, W., Li, W., Yi, X., et al. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2365 · Cited by 7
“FGFs not only presented diversity about biological functions and mechanism/modes of actions,but also have been demonstrated to be able to regulate cell differentiation, proliferation, morphogenesis, metabolism and other fundamental processes([1-4]).”
BackgroundMultiple roles of neuronal extracellular vesicles in neurological disorders
Jiao, Z., He, Z., Liu, N., Lai, Y., & Zhong, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.979856 · Cited by 7
“Although the function of these proteins or genes may also be involved with other disorders and needs to be investigated, it has been confirmed that the disorder of these proteins or their gene expression is involved in the progress or development of neurodegeneration such as major depressive disorder, bipolar disorder…”
BackgroundNeurotrophic Factors and Major Depressive Disorder
Zhang, X., Jin, L., Sha, W., & Bu, R. (2015) · InTech eBooks · doi:10.5772/59373 · Cited by 7
“Affymetrix microarray analyses of cortical brain regions detected a significant number of FGF-related ligand and receptor genes that are differentially expressed in depressed individ‐ uals, including FGF1, FGF2, FGFR2, and FGFR3, which are downregulated, and FGF9 and FGF12, which are upregulated [114].”
BackgroundInfluentialDong, Z., Bi, B., Li, R., Wang, X., Liu, H., Wu, G., Sun, Z., Pu, E., He, C., Zhang, Y., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03738-0 · Cited by 6
Serum Klotho and FGF23 Levels in Patients with Schizophrenia
Kılıçaslan, A. K., Yıldız, S., Emir, B. S., Kılıç, F., & Atmaca, M. (2022) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2022.22406 · Cited by 6
“41,42 Central FGF23 has been found to correlate with impulsive behavior in humans.”
Backgroundvon Hövel, F. F., Leiter, I., Rumpel, R., Langenhagen, A. K., Wedekind, D., Häger, C., Bleich, A., Palme, R., & Grothe, C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112113 · Cited by 6
Malfunction in GABA and Glutamate as Pathways to Depression: A Review of the Evidence
Sharpley, C. F. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s3481 · Cited by 6
Molecular biomarkers in depression: Toward personalized psychiatric treatment
Gururajan, A., Cryan, J. F., & Dinan, T. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00026-2 · Cited by 7
Acute opioid responses are modulated by dynamic interactions of Oprm1 and Fgf12
Lemen, P. M., Zuo, Y., Hatoum, A. S., Dickson, P. E., Mittleman, G., Agrawal, A., Reiner, B. C., Berrettini, W. H., Ashbrook, D. G., Gunturkun, M. H., et al. (2026) · eLife · doi:10.7554/elife.108845 · Cited by 5
“FGF12 expression is also elevated in the anterior cingulate cortex of patients with major depressive disorder (Evans et al., 2004).”
Impact of Experimental Noise and Annotation Imprecision on Data Quality in Microarray Experiments
Scherer, A., Dai, M., & Meng, F. (2013) · Methods in molecular biology · doi:10.1007/978-1-60327-337-4_10 · Cited by 5
Self-citationZhang, L., Zhu, Z.-R., Tan, Z., Luo, H., Hu, X., & Li, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.021 · Cited by 5
Diagnosis of Major Depressive Disorders: Clinical and Biological Perspectives
Fakhoury, M. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_4 · Cited by 5
Ramazi, S., آرانی, ف., Safaei, A., Abbasi, Z., Heidari, Z., Nafchi, H. G., Mohammadsadeghi, H., & Karimzadeh, F. (2021) · The Neuroscience Journal of Shefaye Khatam · doi:10.52547/shefa.9.2.119 · Cited by 5
Biological Alterations in Depression
Benton, C. S., & Wiltshire, T. (2011) · InTech eBooks · doi:10.5772/27658 · Cited by 5
Neurotrophic Factors in Etiology and Treatment of Mood Disorders
Duman, R. S. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn019 · Cited by 5
Hagihara, H., & Miyakawa, T. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03173-7 · Cited by 4
Electroconvulsive Therapy and Heat Shock Gene Inactivation in Neurodegenerative Diseases
Martins, I. J. (2018) · UWA Profiles and Research Repository (UWA) · Cited by 4
Antidepressant-like effects of trophic factor receptor signaling
Sathyanesan, M., & Newton, S. S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.958797 · Cited by 4
Biomarkers For the Diagnosis of Depression: Recent Updates
Kore, M. S., & Prabhavalkar, K. S. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082219666221114114738 · Cited by 4
Liu, J., Yu, J., Liu, H. B., Yao, Q., & Zhang, Y. (2022) · Annals of Nuclear Medicine · doi:10.1007/s12149-022-01790-0 · Cited by 4
“Chronic treatment with fluoxetine also increased the expression of FGF2 in hippocampus [24, 25].”
BackgroundPerspectives for an Integrated Biomarker Approach to Drug Discovery and Development
Antonijevic, I. A., Artymyshyn, R. P., Forray, C., Rabacchi, S. A., Smith, K. E., Swanson, C. J., Tamm, J. A., Mazin, W., & Gerald, C. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_15 · Cited by 4
Blood and Brain Gene Expression in Major Psychiatric Disorders: A Search for Biomarkers
Chana, G., Glatt, S. J., Everall, I., & Tsuang, M. T. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_1 · Cited by 4
Paric, A. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13505 · Cited by 4
Musanabaganwa, C. (2023) · Radboud Repository (Radboud University) · Cited by 4
Prévot, T. D. (2015) · theses.fr (ABES) · doi:10.70675/ede624f4zd89cz47a2z9b47z4074eaaea9b2 · Cited by 5
Paton, S. E. J., Solano, J. L., Collignon, A., Richer, É., Coulombe-Rozon, F., Dion‐Albert, L., Binder, L. B., Dudek, K., Cadoret, A., Lebel, M., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.02.063 · Cited by 3
CHapter 9. Sleep and Circadian Rhythms: An Understudied Area in Treatment Resistant Depression
Armitage, R., & Arnedt, J. T. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197.lg09 · Cited by 3
Implications for the practice of psychiatry
Binder, E. B., & Nemeroff, C. B. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58013-6 · Cited by 3
“Two studies scrutinized major depression (Evans et al., 2004; Aston et al., 2005).”
Olivas, C. A. N., & Solís, E. E. P. (2009) · Cuadernos de neuropsicología · Cited by 3
FGF2 (fibroblast growth factor 2 (basic))
MacFarlane, L., & Murphy, P. R. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44962 · Cited by 3
Levy, M. J. F. (2017) · theses.fr (ABES) · doi:10.70675/be792343za725z4b2czb8c5z8a26a8113d23 · Cited by 3
Astrocyte fatty acid metabolism as a driver of risk for major depressive disorder
Fitzgerald, E., O’Toole, N., Pokhvisneva, I., Nestler, E. J., Turecki, G., Nagy, C., & Meaney, M. J. (2026) · Nature Communications · doi:10.1038/s41467-026-71542-5 · Cited by 2
Karabanov, S. Y., Kibitkina, A. A., Vasilevskaya, E. R., & Fedulova, L. (2024) · Genes and Cells · doi:10.17816/gc631853 · Cited by 2
Turky, M. A., Youssef, I., & Amir, A. E. (2025) · Human Genomics · doi:10.1186/s40246-025-00733-w · Cited by 3
Wei, Z., Zhang, S., Bai, K., Liu, Y., Luan, Y., Hu, Z., Li, Y., Qu, Z., Hu, X., Ding, X., et al. (2025) · Development · doi:10.1242/dev.204532 · Cited by 2
Cortical BDNF and NTRK2 Transcript Expression in Completed Suicide
Strauss, J. S., Luca, V. D., George, C. J., & Kennedy, J. L. (2006) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-006-9020-1 · Cited by 2
“We used publicly available Affymetrix HG-U133A microarray data from 32 postmortem subjects in two cohorts (Evans et al., 2004) to test hypotheses that expression of the BDNF and NTRK2 RNA transcripts would be diminished in suicide compared to other causes of death in anterior cingulate cortex (ACC) and dorsolateral pr…”
BackgroundMethodInfluentialGreden, J. F., Riba, M. B., McInnis, M. G., & Sen, S. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197.lg01 · Cited by 2
Gene Expression Changes and Potential Impact of Endophenotypes in Major Psychiatric Disorders
Chana, G., Kwok, J., Glatt, S. J., Everall, I., & Tsuang, M. T. (2009) · Springer eBooks · doi:10.1007/978-90-481-2298-1_3 · Cited by 2
Dean, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00037-4 · Cited by 2
entre la herencia y la experiencia
Wolf, C. (2011) · Mente y cerebro · Cited by 2
Chapter 10. Psychotherapy Strategies for Treatment Resistant Depression
Flynn, H. A., & Himle, J. A. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197.lg10 · Cited by 2
Neurotrophins and neuronal plasticity in the action of antidepressants and morphine
Sairanen, M. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 2
Mechanistic convergence of depression and suicidality on astrocyte fatty acid metabolismPreprint
Fitzgerald, E., O’Toole, N., Pokhvisneva, I., Turecki, G., Nagy, C., & Meaney, M. J. (2023) · medRxiv · doi:10.1101/2023.03.16.23287352 · Cited by 2
Treatment resistant depression: A case of Muenke syndrome
Faugère, M., Cermolacce, M., Richieri, R. M., & Lançon, C. (2025) · L Encéphale · doi:10.1016/j.encep.2024.10.006 · Cited by 1
Antidepressants in counselling psychology: Relevance, effectiveness and implications for practice
Sharpley, C. F. (2011) · Counselling Psychology Quarterly · doi:10.1080/09515070.2011.589245 · Cited by 1
“, 1999; Rot, Mathew, & Charney, 2009), dysregulation of growth factors in the brain (Evans et al., 2004), interference in DO firing (Chowdary et al.”
BackgroundChromosomal Abnormalities and Putative Susceptibility Genes in Autism Spectrum Disorders
Gilling, M. (2015) · Cited by 1
Chapter 3. Treatment Resistant Depression in Adolescents
Ghaziuddin, N., Barbosa, V. F., & King, C. A. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197.lg03 · Cited by 1
Receptor tyrosine kinases in major depressive disorder
Dakroub, F., El-Orfali, Y., Mantash, S., Alkalamouni, H., Dakroub, R., & Kobeissy, F. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00009-9 · Cited by 1
Chapter 12. Exercise, Nutrition, and Treatment Resistant Depression
Evans, S. J., & Burghardt, P. R. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197.lg12 · Cited by 1
Self-citationKamali, M., & McInnis, M. G. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197.lg15 · Cited by 1
The HPA axis and GABA-Glutamate Systems as Potential Antidepressant Targets in Prostate Cancer
Sharpley, C. F. (2011) · The Open Prostate Cancer Journal · doi:10.2174/1876822901104010001 · Cited by 1
A role for NCAM in depression and antidepressant actions? (Commentary on Aonurm‐Helm et al.)
Sandi, C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06504.x · Cited by 1
Yi, Z., Li, Z., Yu, S., Wang, L., Yuan, C., Hong, W., Shi, T., & Fang, Y. (2012) · European Psychiatry · doi:10.1016/s0924-9338(12)74164-0 · Cited by 1
“The application of high-throughput gene expression profiling to MDD in humans has mostly been restricted to postmortem brain tissue, typically sampled many decades after the critical time frame during which the initial molecular processes underlying the onset and development of disease have occurred, with methodologic…”
BackgroundFibroblast Growth Factor Signalling in the Development of the Midbrain and Anterior Hindbrain
Saarimäki‐Vire, J. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 1
ESTUDO DO EFEITO NEUROPROTETOR DA DULOXETINA
Engel, D. F. (2013) · Americanae (AECID Library) · Cited by 1
Regulación de la plasticidad astrocitaria por ibuprofeno y FGF2
Lichtenstein, M. P. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
An unexpected role for fibroblast growth factor-2 in modulating anxiety and hippocampal stem cells
Pérez, J. A. (2008) · Deep Blue (University of Michigan) · Cited by 1
Vanderzwet, K. (2015) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2015-10820 · Cited by 1
Glucocorticoid regulation of the astrocyte transcriptome in vitro and in vivo.
Carter, B. S. (2013) · Deep Blue (University of Michigan) · Cited by 1
Chapter 11. Device-Related Neuromodulation in Treatment Resistant Depression
Taylor, S. F., Goldman, M., Maixner, D. F., Patil, P. G., & Greden, J. F. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197.lg11 · Cited by 1
The genomics of mood disorders
Alesci, S., Rodak, M., Ilias, Ι., Zhou, R., & Manji, H. K. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58006-9 · Cited by 1
Detera‐Wadleigh, S. D., & Yoshikawa, T. (2008) · Nucleic acids and molecular biology · doi:10.1007/978-3-540-85383-1_1
“Evans and others found altered expression of fibroblast growth factor (FGF)-related genes in major depression by comparing 21 FGF genes systematically (Evans et al. 2004).”
BackgroundResultElucidating mechanisms of accelerated neurological aging
Greenhall, J. A. (2008) · eScholarship (California Digital Library)
Proteomics Providing Insights into Major Psychiatric Disorders
Föcking, M., Pennington, K., English, J., Dunn, M. J., & Cotter, D. (2007) · Wiley eBooks · doi:10.1002/9783527622153.ch22
Neurobiologic Foundations of Mood Disorders
Polan, H. J., Duman, R. S., & Schatzberg, A. F. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch21
Bipolar Disorder: not only in the Brain - immunological aspects
Knijff, E. M. (2006) · RePub (Erasmus University Rotterdam)
Chauhan, R. B. (2012) · Deep Blue (University of Michigan)
A Role for the Fibroblast Growth Factor Family in Depression and Circadian Rhythms.
Inui, E. G. (2010) · Deep Blue (University of Michigan)
A role for astroctye-related genes in suicide
Ernst, C. (2009)
Marcadores biológicos e nível de funcionalidade em pacientes bipolares
Rosa, A. R. (2007) · Lume (Universidade Federal do Rio Grande do Sul)
Oliveira‐Giacomelli, Á. (2014)
Depression Can Aggravate Symptoms Associated With Dupuytren’s Contracture
Osuagwu, F. C., Noveloso, B. D., Amalraj, B., Hashmi, S., & Reddy, V. (2015) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.15l01832
Le-Niculescu, H., Balaraman, Y., Patel, S. D., Tan, J., Paulus, M. P., Kuczenski, R. T., Niculescu, A. B., McFarland, M. J., Ca, O., Za, R., et al. (2008)
Analisi dei profili di espressione dei microRNA: identificazione di biomarker nel suicidio
Niola, P. (2016) · VEprints - Universita degli Studi di Cagliari
Translational Research in Psychiatric Diseases
McInnis, M. G. (2007) · CRC Press eBooks · doi:10.3109/9781420019544-13
The Roles of ERK1 and ERK2 MAP Kinase in Neural Development and Disease
Samuels, I. S. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Pucilowska, J. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
Resilience Through Attending to the Power of the Mind
Behm, J. D. (2011) · JMU Scholoraly Commons (James Madison University)
Treatment-Resistant Depression, Obesity, and Adiponectin
Sitzmann, A. F. (2015) · Deep Blue (University of Michigan)
The Role of Intracellular Signaling Pathways in the Neurobiology of the Depressive Disorder.
Kim, S. H. (2011) · Saengmul jeongsin euihag/Saengmul jeongsin uihak
Azevedo, J. A. (2016) · Deep Blue (University of Michigan)
Individual Differences Make a Marker in Fear Research
Prater, K. E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.07.015
“FGF2 is known to be downregulated in the postmortem brains of patients with major depressive disorder (4).”
BackgroundZur Funktion der Corticotropin releasing hormone Rezeptoren in der Maus
Wunsch, J. (2006) · mediaTUM (Technical University of Munich)
Regulation of System XC- and its Contribution to Cell Death
Liu, X. (2012) · e-Publications@Marquette (Marquette University)
Farnaz, E. (2018) · University of Malaya Students Repository
Littlejohn, E. L. (2018) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2018.292
Levone, B. R. (2018) · Arrow@dit (Dublin Institute of Technology)
Çelik, C., Bolu, A., Öznur, T., Aydın, M. S., Tokgöz, Y., & Uzun, Ö. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.1.74
Hippocampal FGF-antisense overexpression increase depression-like behaviour in the rat
Uzay, B., Karataş, H., Yemişçi, M., Dalkara, T., & Eren‐Koçak, E. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.566
Shail, P. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13423
Hercher, C. (2008) · eScholarship@McGill (McGill) · doi:10.82308/4899
Sex Differences in the Behavioural Response to FGF2 Administration
Pepe, A. (2018) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2018-12703
The Role of Fibroblast Growth Factor 2 in Energy Balance and Metabolism
Alam, S. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13849
Metadata
- Authors
- Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., Walsh, D. M., Myers, R. M., Bunney, W. E., Watson, S. J., Jones, E. G., & Akil, H.
- Affiliations
- University of California, Irvine (US)
- Department of Psychiatry and Mental Health Research Institute, University of Michigan, Ann Arbor, MI 48109; Human Genome Center, Stanford University, Palo Alto, CA 94304; Center for Neuroscience, University of California, Davis, CA 95616; and Department of Psychiatry and Human Behavior, University of California, Irvine, CA 92697
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-10-13
- Volume
- 101
- Issue
- 43
- Pages
- 15506-15511
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC523463
- OpenAlex
- W2150092716
- Cited by
- 424
- References
- 38
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 20 · 2023: 15 · 2022: 19 · 2021: 21 · 2020: 10 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 15 · 2015: 23 · 2014: 15 · 2013: 20 · 2012: 20
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Michigan
- National Institutes of Health
- University of California, Davis
- University of California, Irvine
- National Institute of Mental Health (P50MH060398, #L99MH60398)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, gene expression dysregulation, frontal cortex, bipolar disorder, serotonin reuptake inhibitors, antidepressant mechanism, growth factor receptors, postmortem brain
- MeSH terms
- Adult, Aged, Aged, 80 and over, Major Depressive Disorder, Female, Fibroblast Growth Factors, Humans, Male, Middle Aged, Polymerase Chain Reaction, Selective Serotonin Reuptake Inhibitors, In Situ Hybridization, Oligonucleotide Array Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.